- Home
- CLPS vs DRRX Comparison
CLPS vs DRRX Comparison
Compare CLPS & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- DRRX
- Stock Information
- Founded
- CLPS 2005
- DRRX 1998
- Country
- CLPS Hong Kong
- DRRX United States
- Employees
- CLPS N/A
- DRRX N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- CLPS Technology
- DRRX Health Care
- Exchange
- CLPS Nasdaq
- DRRX Nasdaq
- Market Cap
- CLPS 31.2M
- DRRX 26.4M
- IPO Year
- CLPS 2018
- DRRX 2000
- Fundamental
- Price
- CLPS $1.21
- DRRX $0.85
- Analyst Decision
- CLPS
- DRRX Buy
- Analyst Count
- CLPS 0
- DRRX 2
- Target Price
- CLPS N/A
- DRRX $5.00
- AVG Volume (30 Days)
- CLPS 16.5K
- DRRX 124.4K
- Earning Date
- CLPS 03-04-2025
- DRRX 11-13-2024
- Dividend Yield
- CLPS 10.74%
- DRRX N/A
- EPS Growth
- CLPS N/A
- DRRX N/A
- EPS
- CLPS N/A
- DRRX N/A
- Revenue
- CLPS $142,812,726.00
- DRRX $8,594,000.00
- Revenue This Year
- CLPS N/A
- DRRX $54.32
- Revenue Next Year
- CLPS N/A
- DRRX N/A
- P/E Ratio
- CLPS N/A
- DRRX N/A
- Revenue Growth
- CLPS N/A
- DRRX N/A
- 52 Week Low
- CLPS $0.68
- DRRX $0.68
- 52 Week High
- CLPS $1.70
- DRRX $1.88
- Technical
- Relative Strength Index (RSI)
- CLPS 61.75
- DRRX 47.88
- Support Level
- CLPS $1.08
- DRRX $0.79
- Resistance Level
- CLPS $1.18
- DRRX $0.86
- Average True Range (ATR)
- CLPS 0.05
- DRRX 0.08
- MACD
- CLPS 0.01
- DRRX 0.01
- Stochastic Oscillator
- CLPS 100.00
- DRRX 51.69
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .